NSD1 expression correlates with Akt/mTORC1 pathway activity in head and neck squamous cell carcinoma
Open Access
- 19 June 2026
- journal article
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 13 (2) , 102-112
Abstract
Introduction. Histone methyltransferase NSD1 is often inactivated in head and neck squamous cell carcinoma. Loss of NSD1 is associated with improved prognosis in HPV (human papilloma virus) negative cancer. However, data on the signaling pathways regulated by NSD1 are limited. Aim. Validation and systemic assessment of reproducibility of the NSD1-Akt/mTORC1 axis based on integrative analysis of open transcriptomic and proteomic data from cell lines and samples of head and neck squamous cell carcinoma. Materials and methods. Systemic analysis was performed of the connection between NSD1 and Akt/mTORC1 signaling pathway using open transcriptomic and proteomic data (panel of squamous cell carcinoma cell lines on the DepMap portal and clinical cohorts from the The Cancer Genome Atlas (TCGA)). Pathway activity was evaluated using ssGSEA/GSEA (single-sample Gene Set Enrichment Analysis), proteomic activity – using protein expression data obtained with Reverse Phase Protein Array (RPPA), statistical significance – using standard correlation and nonparametric tests. Results. In the cell line panel, elevated NSD1 expression correlated with stronger PI3K/AKT/mTOR transcription signature and increased phosphorylation of the key pathway components according to RPPA data. Similar correlation was observed in patient tumor samples. Data on isogenic cell lines with NSD1 knockout demonstrated decreased expression of mTORC1 target genes. Conclusion. Reproducible correlation between NSD1 level and Akt/mTORC1 signaling pathway activity in head and neck cancer was established. However, additional confirmation of the NSD1 role in regulation of the Akt/mTORC1 pathways requires in vitro and in vivo investigation of expression and phosphorylation of protein components of this cascade, as well as functional experiments to evaluate proliferation, survival and drug sensitivity of head and neck cancer cells. Clinical significance of the established correlation in the context of disease progression requires further verification.Keywords
This publication has 24 references indexed in Scilit:
- Uncovering chromatin factor landscapes in head and neck squamous cell carcinomaOral Oncology, 2025
- NSD1 promotes esophageal cancer tumorigenesis via HIF1α signalingCell Biology and Toxicology, 2022
- Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomasMolecular Cell, 2022
- The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumorsCellular and Molecular Life Sciences, 2022
- Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinomaCell Reports, 2021
- Head and neck squamous cell carcinomaNature Reviews Disease Primers, 2020
- NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosisNature Communications, 2017
- Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomasNature Genetics, 2017
- Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 2015
- mTOR Signaling in Growth Control and DiseaseCell, 2012